You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

3-epi-25(OH)D3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitamin D Deficiency Trial in Jakarta Pusat (Cholecalciferol)

Active, not recruiting
  • Vitamin D Deficiency
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo National Center General Hospital
Sep 22, 2023

Vitamin D Deficiency, 25-Hydroxyvitamin D3 Deficiency, Selective Trial in Cuernavaca (vitamin D-enhanced egg, Control)

Completed
  • Vitamin D Deficiency
  • 25-Hydroxyvitamin D3 Deficiency, Selective
  • vitamin D-enhanced egg
  • Control
  • Cuernavaca, Morelos, Mexico
    Instituto Nacional de Salud Pública
Oct 19, 2023

Chronic Kidney Disease Trial in Seattle (D6-25-hydroxyvitamin D3)

Completed
Has Results
  • Chronic Kidney Disease
  • D6-25-hydroxyvitamin D3
  • Seattle, Washington
    University of Washington
May 14, 2022

Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid

Recruiting
  • Nutrition, Healthy
  • DHA/EPA bioenhanced chicken
  • 25(OH)D bioenhanced chicken
  • Ithaca, New York
    Human Metabolic Research Unit
Jun 3, 2022

Vitamin D Deficiency Trial in Warszawa (Cholecalciferol 120 000 IU)

Completed
  • Vitamin D Deficiency
  • Cholecalciferol 120 000 IU
  • Warszawa, Poland
    Department of Endocrinology, Centre of Postgraduate Medical Educ
Oct 19, 2022

Mental Health Issue Trial in Haveli (25 hydroxy cholecalciferol (Vitamin D) /25(OH)D3., Placebo)

Not yet recruiting
  • Mental Health Issue
  • 25 hydroxy cholecalciferol (Vitamin D) /25(OH)D3.
  • Placebo
  • Haveli, Azad Jammu And Kashmir, Pakistan
    District Headquarter Hospital Haveli
Oct 24, 2023

Multiple Sclerosis, Relapsing-Remitting, Adult ALL, Vitamin D3 Deficiency Trial (25(OH)D3, vitamin D3)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
  • 25(OH)D3
  • vitamin D3
  • (no location specified)
Apr 16, 2022

Optimized 3D EPI SWI Sequence andNon-EPI QSM SWI Sequence in

Recruiting
  • Multiple Sclerosis
  • cerebral MRI
  • Paris, France
    Hhopital fondation adolphe de rothschild
Apr 6, 2022

Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)

Completed
  • Pituitary ACTH Hypersecretion
  • +3 more
  • Cholecalciferol 15000 UNT/ML Oral Solution
  • Moscow, Russian Federation
    Endocrinology Research Centre, Moscow
Aug 10, 2022

COVID-19, Vitamin D Deficiency Trial in Riga (Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion)

Completed
  • COVID-19
  • Vitamin D Deficiency
  • Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion
  • Riga, Latvia
    Pauls Stradins Clinical Univeristy Hospital
Aug 15, 2022

Vitamin D Deficiency Trial in Los Angeles (Vitamin D, 25(OH)D3)

Completed
  • Vitamin D Deficiency
  • Los Angeles, California
  • +1 more
Apr 26, 2021

Pre-Diabetic Trial in Rochester (Calcitriol capsules, Oral Placebo)

Terminated
Has Results
  • Pre-Diabetic
  • Calcitriol capsules
  • Oral Placebo
  • Rochester, Minnesota
    Mayo Clinic
Feb 17, 2022

Osteoporosis Trial (MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet)

Completed
Has Results
  • Osteoporosis
  • MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet
  • (no location specified)
Feb 1, 2022

25-hydroxyvitamin D Levels Trial in Amman (Dietary Supplement: Omega3-FA)

Completed
  • 25-hydroxyvitamin D Levels
  • Dietary Supplement: Omega3-FA
  • Amman, Jordan
    Mahmoud S Abu-Samak
Feb 23, 2022

Chronic Kidney Disease Trial in Seattle (D6-25-hydroxyvitamin D3)

Completed
Has Results
  • Chronic Kidney Disease
  • D6-25-hydroxyvitamin D3
  • Seattle, Washington
    University of Washington
Aug 31, 2021

Neonatal Neurobehavior, Breastfeeding Outcomes Trial in Cleveland (Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour

Withdrawn
  • Neonatal Neurobehavior
  • Breastfeeding Outcomes
  • Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour 0.25% bupivacaine and epi 1:800,000
  • +3 more
  • Cleveland, Ohio
    University Hospitals Case Medical Center
Apr 13, 2022

Cystic Fibrosis Trial in Seattle (d6-25-hydroxyvitamin D3)

Active, not recruiting
  • Cystic Fibrosis
  • d6-25-hydroxyvitamin D3
  • Seattle, Washington
    University of Washington
Sep 27, 2021

Vitamin D Deficiency Trial in Le Sueur (dietary supplement, diagnostic test, other)

Completed
  • Vitamin D Deficiency
  • Softgel Vitamin D3
  • +3 more
  • Le Sueur, Minnesota
    Inspired Life Medical Office
Aug 23, 2021

Cardiovascular Disease, Vitamin D Deficiency Trial in Murray (Vitamin D3, Placebo)

Completed
  • Cardiovascular Disease
  • Vitamin D Deficiency
  • Vitamin D3
  • Placebo
  • Murray, Utah
    Intermountain Heart Institute
Apr 1, 2021

Non-allergic Asthma, Obesity, Vitamin D Deficiency Trial in Mexico City (Vitamin D3 (25-hydroxy vitamin D))

Recruiting
  • Non-allergic Asthma
  • +2 more
  • Vitamin D₃ (25-hydroxy vitamin D)
  • Mexico City, Mexico
    Hospital Infantil de México Federico Gómez
Jun 24, 2022

Mild to Moderate Anterior Mandibular Segment Crowdind Trial in Latakia (Dihydroxycholecalciferols, dimethyl sulfoxide, serum)

Completed
  • Mild to Moderate Anterior Mandibular Segment Crowdind
  • Latakia, Syrian Arab Republic
    Tishreen University - Faculty of dentistry
Sep 26, 2022

Chronic Heart Failure, Vitamin D Adverse Reaction Trial in Budapest (Vigantol oil and MCT oil)

Terminated
  • Chronic Heart Failure
  • Vitamin D Adverse Reaction
  • Vigantol oil and MCT oil
  • Budapest, Hungary
  • +1 more
Apr 8, 2021

Vitamin D Deficiency, Scleroderma, Systemic Trial in Mexico City (Vitamin D3, Dietary recommendations)

Completed
  • Vitamin D Deficiency
  • Scleroderma, Systemic
  • Vitamin D3
  • Dietary recommendations
  • Mexico City, Mexico
    Instituto Méxicano del Seguro Social
Apr 19, 2021

Macrophage Migration Inhibitory Factor and 25(OH) Vitamin D3

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Jan 24, 2021

    Cocaine Use Disorder Trial in New Haven (Calcitriol, Placebo)

    Suspended
    • Cocaine Use Disorder
    • New Haven, Connecticut
      Connecticut Mental Health Center
    Jul 11, 2022